Kanzaki, Hiromitsu http://orcid.org/0000-0003-4326-6979
Hamamoto, Yasushi
Nagasaki, Kei
Kozuki, Toshiyuki
Funding for this research was provided by:
AstraZeneca
Eli Lilly Japan
Chugai Pharmaceutical
MSD
Merck
Article History
Received: 1 February 2021
Accepted: 28 April 2021
First Online: 17 May 2021
Declarations
:
: Toshiyuki Kozuki received honorarium from AstraZeneca and Eli Lilly Japan, and received research funding Chugai Pharmaceutical Co., MSD, and Merck Biopharma. All other authors declare that they have no conflict of interest.
: The protocol of this study was received and approved by our institutional ethical committee. All procedures performed in these studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments.